MarketScreener Homepage > Equities > Tokyo Stock Exchange > Sumitomo Chemical Company, Limited 4005 JP3401400001

Report

End-of-day quote Tokyo Stock Exchange - 11/26
384	JPY		-1.54%

11/26

SUMITOMO DAINIPPON PHARMA : Urovant Sciences Announces Topline Data from Phase 2a Study of Vibegron for the Treatment of Irritable Bowel Syndrome Pain Did Not Meet Primary Endpoint

11/23

Poxel Provides Update on Metavant Partnership with Imeglimin

11/16

SUMITOMO CHEMICAL : Launches SynBio Hub a New Organization in the US to Accelerate Next-Generation Business Utilizing Synthetic Biology

Summary

Quotes 5-day view End-of-day quote.

End-of-day quote Tokyo Stock Exchange

11/24/2020	11/25/2020	11/26/2020	11/27/2020	11/30/2020	Date
388	390	384	385	370	Last
8199600	10025800	7960600	11106200	18258800	Volume
+0.78%	+0.52%	-1.54%	+0.26%	-3.90%	Change

Financials

Sales 2021	2 200 B 21 092 M 21 092 M
Net income 2021	27 675 M 265 M 265 M
Net Debt 2021	1 177 B 11 280 M 11 280 M
P/E ratio 2021	21,9x
Yield 2021	2,97%

Sales 2022	2 316 B 22 204 M 22 204 M
Net income 2022	61 970 M 594 M 594 M
Net Debt 2022	1 138 B 10 906 M 10 906 M
P/E ratio 2022	9,76x
Yield 2022	3,57%

Capitalization	605 B 5 794 M 5 795 M
EV / Sales 2021	0,81x
EV / Sales 2022	0,75x
Nbr of Employees	33 586
Free-Float	96,7%

More Financials

Company

Sumitomo Chemical Co Ltd is one of the Japanese largest chemical groups. The group is also manufacturing and marketing pharmaceutical products. Net sales break down by family of products as follows: - petrochemical and plastic products (29.5%): ethylene, polyethylene, propylene, elastomers, agricultural films, etc.; - pharmaceutical products (23.2%): ethic drugs, radiopharmaceutical products, etc.; -...

Sector

Diversified Chemicals

Calendar

01/29

Earnings Release

More about the company

Notations Surperformance© of Sumitomo Chemical Company, Limited

Trading Rating :

Investor Rating :

More Ratings

All news about SUMITOMO CHEMICAL COMPANY, LIMITED

11/26	SUMITOMO DAINIPPON PHARMA : Urovant Sciences Announces Topline Data from Phase 2..	AQ
11/23	Poxel Provides Update on Metavant Partnership with Imeglimin	AQ
11/16	SUMITOMO CHEMICAL : Launches SynBio Hub a New Organization in the US to Accelera..	AQ
11/16	SUMITOMO DAINIPPON PHARMA : Sumitovant Enters into an Agreement for 'Going Priva..	AQ
11/13	Myovant Sciences Announces Corporate Updates and Financial Results for Second..	AQ
11/02	SUMITOMO CHEMICAL : Reports Consolidated Financial Results For the Half-Year End..	AQ
11/02	SUMITOMO CHEMICAL : Enactment of the Tax Policy of Sumitomo Chemical Group	AQ
10/30	SUMITOMO CHEMICAL COMPANY, LIMITED : Half-year results	CO
10/29	SUMITOMO DAINIPPON PHARMA : Announces Revisions to Its Financial Forecasts	AQ
10/28	Poxel Announces Participation at Several Upcoming Scientific and Investor Con..	AQ
10/27	SUMITOMO DAINIPPON PHARMA : Joint Research and Development Agreement with Drawbr..	AQ
10/22	SUMITOMO CHEMICAL : - COMFORMER a resin heat storage material for textile use is..	AQ
10/21	Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Qu..	AQ
10/16	Poxel Secures EUR 6 Million in Non-Dilutive Financing Guaranteed by the Frenc..	AQ
10/09	SUMITOMO CHEMICAL : Strengthens Its Crop Protection Business for Sustainable Agr..	AQ

More news

News in other languages on SUMITOMO CHEMICAL COMPANY, LIMITED

07/09	NOUVELLE-ZÉLANDE : Rio Tinto va fermer sa fonderie avec un millier d'employés
05/12	SUMITOMO CHEMICAL COMPANY, LIMITED : Veröffentlichung des Jahresergebnisses
05/12	SUMITOMO CHEMICAL COMPANY, LIMITED : publication des résultats annuels
2013	SUMITOMO CHEMICAL CO LTD : publication des résultats trimestriels

More news

Analyst Recommendations on SUMITOMO CHEMICAL COMPANY, LIMITED

2018	Roundup cancer verdict sends Bayer shares sliding	RE
2018	Roundup cancer verdict sends Bayer shares sliding	RE

More recommendations

Provided by Scoopnest.com

Chart SUMITOMO CHEMICAL COMPANY, LIMITED

Duration : Period :

Sumitomo Chemical Company, Limited Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends SUMITOMO CHEMICAL COMPANY, LIMITED

	Short Term	Mid-Term	Long Term
Trends	Bullish	Bullish	Neutral

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	OUTPERFORM
Number of Analysts	10
Average target price	414,00 JPY
Last Close Price	370,00 JPY
Spread / Highest target	35,1%
Spread / Average Target	11,9%
Spread / Lowest Target	-8,11%

Consensus

EPS Revisions

More Estimates Revisions

Managers

Name	Title
Keiichi Iwata	President & Representative Director
Masakazu Tokura	Chairman
Keigo Sasaki	Head-Corporate Communication & Finance
Hiroshi Ueda	Director & Vice President
Rei Nishimoto	Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

SUMITOMO CHEMICAL COMPANY, LIMITED	-22.89%	6 048



SHIN-ETSU CHEMICAL CO., LTD.	39.68%	67 645
BASF SE	-9.55%	66 898
DUPONT DE NEMOURS, INC.	0.53%	47 363
ROYAL DSM N.V.	18.00%	27 776
FMC CORPORATION	15.88%	15 009

More Results